Colombia Medical Device Regulations run under one national decree, with INVIMA as the sole authority reviewing and approving devices for the market. The applicable requirement depends mainly on the product’s classification and on whether it is manufactured locally or imported, so getting that classification right upfront decides everything else in the file.
This article covers Medical Device Registration in Colombia end to end, from classification through post-market obligations.
Regulatory Authorities for Medical Devices in Colombia
- INVIMA: Colombia’s national sanitary authority for medical devices. It issues sanitary registrations and automatic registrations for standard devices, plus permisos de comercialización (commercialization permits) for controlled-technology biomedical equipment. It also runs inspection, surveillance, enforcement activities, and can suspend or cancel an authorization when a product fails to meet its conditions.
- Ministerio de Salud y Protección Social: Operates above INVIMA in the regulatory chain. Decrees, technical regulations, INVIMA administers what this ministry issues. Good Manufacturing Practices (GMP) standards and labeling rules included.
- DIAN (Dirección de Impuestos y Aduanas Nacionales): Handles the customs side. DIAN manages the actual import declaration and nationalization of goods at the border. INVIMA does not clear customs.
- VUCE (Ventanilla Única de Comercio Exterior): The channel through which INVIMA issues its sanitary “visto bueno” (import clearance approval), a prerequisite that has to be secured before the shipment can be nationalized through DIAN.
This distinction trips people up constantly. A sanitary registration is not a customs clearance, and having one does not mean the product automatically sails through the border.
Colombia Medical Device Classification
Colombia Medical Device Classification runs on a four-tier, risk-based system defined in Decreto 4725 de 2005. It is not the EU MDR system copied over with different labels, even though the classes carry the same names. Colombia has its own classification rules.
| Class | Risk level | Description | Regulatory outcome | Typical examples |
| Class I | Low | Subject to general controls, not intended to protect or sustain life | Automatic sanitary registration | Non-sterile bandages, manual wheelchairs, tongue depressors |
| Class IIa | Moderate | Subject to special controls at the manufacturing stage | Automatic sanitary registration | Ultrasound gel, hearing aids, hydrophilic dressings |
| Class IIb | High | Subject to special controls at the design and manufacturing stage | Standard sanitary registration | Infusion pumps, ventilators, blood bags |
| Class III | Very high | Life-sustaining or life-supporting devices, or devices carrying a real potential for illness or injury | Standard sanitary registration | Heart valves, coronary stents, implantable pacemakers |
Classification depends on the device’s intended purpose, how long it stays in contact with the body, whether it is invasive and whether it is active or implantable, following the 18 classification rules in Article 7.
A device meant to stay inside the body for more than 30 days after a surgical procedure counts as implantable under Article 2, and that alone pushes many products into Class IIb or III. Software bundled with a device is classified in the same class as the device it controls.
Manufacturers classify their own product in the first instance, and the classification has to reflect the device’s actual intended use rather than an assumption borrowed from another market.
Medical Device Registration Requirements and Registration Routes in Colombia
INVIMA Medical Device Registration takes one of three forms depending on classification.
Registro sanitario automático (automatic sanitary registration): Applies to Class I and Class IIa devices under Article 17. Once the file is complete, INVIMA issues the administrative act within two business days. Here “automatic” does not mean “unreviewed.” INVIMA still checks the file and can suspend the registration later if the submitted information does not hold up.
Registro sanitario (standard sanitary registration): Applies to Class IIb and Class III devices under Article 16. This involves a full technical and legal evaluation and for these two classes specifically, clinical evidence supporting safety and effectiveness has to be submitted along with a risk analysis as per Article 18.
Permiso de comercialización (commercialization permit): A distinct category outside standard registration, for controlled-technology biomedical equipment. This covers high-investment equipment, prototypes, used or repowered equipment and certain Class IIb and III devices tied to health-sector planning rules under Article 65 of Ley 715 de 2001.
Authorized Representative and Local Representation Requirements in Colombia
Foreign manufacturers cannot register a device directly with INVIMA on their own. There has to be a Colombian party in the picture, and Decreto 4725 gives that role to the importer, not to a separate “authorized representative” figure.
The Colombian importer submits the registration application and holds the Certificado de Capacidad de Almacenamiento y Acondicionamiento (CCAA). It is named directly on the sanitary registration under Article 20.
The manufacturer’s role is to issue a letter authorizing that specific importer to register, distribute and be the titular (rights holder) of the registration as per Article 29. That authorization document, along with proof of the manufacturer’s legal existence, has to come from the country of origin and be apostilled or consularized if issued abroad, under Article 44.
Colombia does not use the EU concept of an Authorized Representative as a standing regulatory contact independent of commercial activity. The importer is the regulatory contact, and if that importer relationship ends, the manufacturer’s Colombian regulatory presence typically ends with it unless a transfer is properly filed.
Medical Device Regulatory Guidelines in Colombia
Colombia’s medical device rules are spread across a base decree and a handful of resolutions that build on it.
- Decreto 4725 de 2005 is the core regulation, issued by the then Ministerio de la Protección Social (now the Ministerio de Salud y Protección Social).
- Amendments: Decreto 3275 de 2009, Decreto 4562 de 2006 and Decreto 582 de 2017 have all modified the original decree, which remains in force under the Decreto Único Reglamentario del Sector Salud (Decreto 780 de 2016), specifically excluded from full repeal.
- Resolución 4816 de 2008 created Colombia’s Tecnovigilancia program and governs post-market surveillance.
- Resolución 4002 de 2007 develops the storage and manufacturing capacity conditions (CCAA) referenced in Articles 16 and 17 of the decree.
Manufacturers should monitor the INVIMA regulatory library (normograma) and the Diario Oficial for updates. Colombia doesn’t replace the whole decree at once. Amendments and implementing resolutions are issued on a rolling basis instead.
QMS Requirements for Medical Devices in Colombia
Colombia requires manufacturers to maintain a Quality Management System (QMS). At its core sits Buenas Prácticas de Manufactura (BPM), Colombia’s own Good Manufacturing Practices standard for medical devices. INVIMA certifies compliance under Articles 8 and 9.
Manufacturers need a Certificado de Cumplimiento de BPM. Until that certification is phased in, a Concepto Técnico de las Condiciones Sanitarias applies instead. Both are valid for five years under Article 15. Importers and distributors follow a separate track. They need the CCAA rather than BPM, since they are not manufacturing the device themselves.
ISO 13485 shows up in the decree as supporting evidence, not as the legal basis for market access. Under Article 24, an ISO 13485 certificate (or an equivalent recognized quality system certificate) can substitute for a specific quality certification when importing controlled-technology equipment, alongside a certificate of free sale.
Medical Device Registration Process in Colombia
The Colombia Medical Device Registration Process generally follows this practical order.
Step 1: Confirm the product meets Colombia’s definition of a medical device.
Article 2 of Decreto 4725 defines a medical device broadly. Instruments, equipment, software and accessories used for diagnosis, prevention, treatment or monitoring, all of it counts. Custom-made devices and in vitro diagnostic reactives don’t. Those are excluded from this decree under Article 1. They follow separate rules.
Step 2: Determine the intended use and clinical scope.
The finalidad prevista (intended purpose) drives the classification rules that follow, and it has to match what appears later on the label and in the technical file. A device with more than one intended use gets classified by its most critical application under Article 6.
Step 3: Classify the device using Articles 5 through 7.
Run the product through Colombia’s own 18 classification rules rather than importing a class from another market. This single step decides which registration route applies and what documentation gets requested.
Step 4: Identify whether automatic registration, standard registration or a commercialization permit applies.
Class I and IIa go through automatic registration under Article 17. Class IIb and III go through standard registration under Article 16. Controlled-technology equipment goes through a commercialization permit under Article 23, regardless of class.
Step 5: Confirm the Colombian importer relationship and gather the manufacturer’s authorization letter.
Since Colombia does not use an EU-style Authorized Representative, the importer has to be locked in before filing, holding a valid CCAA and named as titular on the authorization letter under Article 29.
Step 6: Prepare the technical dossier.
This includes product description, technical specifications, and, for Class IIa, IIb and III, verification and validation data. Class IIb and III devices additionally need a risk analysis and clinical evidence of safety and effectiveness under Article 18.
Step 7: Prepare labeling and Instructions for Use (IFU) in Spanish.
Articles 54 and 55 set out what has to appear on the label, and getting the artwork finalized early avoids a late-stage delay once the rest of the file is otherwise ready.
Step 8: Obtain the certificate of free sale and applicable quality certificates.
The certificate of free sale from the country of origin (or a reference country under Article 29) has to be apostilled or consularized. BPM, CCAA or ISO 13485 supporting documents get attached depending on whether the applicant is a manufacturer or importer.
Step 9: File the application through INVIMA’s Oficina Virtual electronic system.
INVIMA checks that the submission is complete before it enters the review queue. An incomplete file gets flagged rather than reviewed, so a pre-submission checklist pass saves real time here.
Step 10: Respond to any INVIMA information request.
Applicants generally get 90 calendar days to respond to a single request under Articles 21 and 22. Missing this window means the application is treated as abandoned, and the fee already paid is not refunded.
Step 11: Receive the sanitary registration, automatic registration, or commercialization permit.
The registration is valid for 10 years under Article 31, and it will list the classification, modality, titular and authorized importer.
Step 12: Complete the VUCE import authorization and begin commercialization.
A separate sanitary “visto bueno” through VUCE is needed before the first shipment can be nationalized through DIAN, and commercialization has to start within 36 months of the registration date under Article 46, or the registration is automatically canceled.
Required Documents for Medical Device Registration in Colombia
Documentation requirements shift depending on classification and modality. Not every item below applies to every filing.
- Manufacturer’s legal existence and representation documents
- Colombian importer’s legal existence documents and CCAA
- Manufacturer’s authorization letter naming the importer as titular
- Product description, intended use, and classification rationale
- Technical specifications and, for Class IIa, IIb and III, verification and validation data or a certificate of analysis
- Risk analysis and, for Class IIb and III, clinical evidence of safety and effectiveness
- Certificate of free sale from the country of origin (or a reference-country certificate where the product is not sold domestically there), apostilled or consularized
- Labels and inserts in their final artwork
- Quality certification (BPM, CCAA, or equivalent) depending on whether the applicant is a manufacturer or importer
Documents issued abroad need official Spanish translation when not already in Spanish, under Article 44.
Medical Device Labeling & IFU Requirements in Colombia
Spanish-language labeling is not optional. Article 54 requires product name, lot or serial number, expiration date where applicable, the registration or permit number and manufacturer and importer information to appear in Spanish (castellano) on the primary label. Article 55 adds a longer list of conditional requirements depending on device type, covering warnings, sterility indications, storage conditions and reuse instructions.
Devices imported with original foreign-language labeling do not need to be relabeled at origin. Article 57 allows a supplementary Spanish label or sticker instead, covering the importer’s name, address and the registration number, as long as it does not obscure the original label.
English-language technical or scientific documentation is accepted with an official Spanish translation as per Article 49, but that applies to supporting technical files, not to the consumer-facing label itself.
CE marking, FDA clearance, or any other foreign approval does not substitute for Colombian labeling requirements or for the sanitary registration itself.
Registration Timelines for Medical Devices in Colombia
Automatic registration for Class I and IIa devices moves fastest. INVIMA issues the act within two business days of a complete file, under Article 22. Where INVIMA raises an information request, applicants get 90 calendar days to respond and missing that window means the application is treated as abandoned.
Facility inspections follow their own clock. INVIMA has up to 90 business days to conduct the BPM or CCAA inspection visit once a complete application is filed, under Article 13. Renewals need to be filed three months before the existing registration expires and this deadline is worth building into an internal compliance calendar well ahead of time.
For Class IIb and III devices, INVIMA has 90 business days to process a standard sanitary registration or commercialization permit once the complete technical and legal file has been submitted, separate from the 90-day window applicants get to respond to an information request.
Medical Device Registration Costs in Colombia
INVIMA fees are published each year in the Manual Tarifario and calculated in Unidad de Valor Básico (UVB) rather than fixed peso amounts, so the peso value shifts slightly whenever the UVB is updated. Under Resolución 2025067543 del 22 de diciembre de 2025, the current medical device codes are:
Code 3003: Sanitary registration or automatic renewal for Class I and IIa devices and non-controlled biomedical equipment, at 321.91 UVB (approximately COP 3,898,330).
Code 3004: Sanitary registration or renewal for Class IIb and III devices, at 364.36 UVB (approximately COP 4,413,000).
Code 3005: Commercialization permit or renewal for controlled-technology biomedical equipment, at 367.92 UVB (approximately COP 4,455,511).
These fees cover only the INVIMA administrative charge. They do not include consulting fees, document legalization or apostille costs, official translation or laboratory testing. All of these are separate commercial expenses and not part of the government fee.
Import Requirements for Medical Devices in Colombia
A valid sanitary registration or commercialization permit is the starting point for importing a medical device into Colombia. Before the shipment arrives, the importer requests the sanitary “visto bueno” through the VUCE, referencing the existing registration.
INVIMA reviews and issues this clearance. But the actual customs declaration and nationalization of the goods runs through a separate authority, DIAN, under its own customs regulations. Both steps are required, and clearing one does not clear the other.
The importer named on the registration also carries ongoing responsibilities. It holds the CCAA, maintains the storage and handling conditions INVIMA certified and keeps traceability records under Article 63. Temporary imports, such as short-term demonstration equipment, follow separate rules, with a maximum window of six months (extendable by three) for short-term imports and five years for long-term capital-equipment imports. Samples with no commercial value and donated equipment follow their own authorization tracks through INVIMA’s Grupo de Autorizaciones y Licencias.
Post-Market Surveillance Requirements in Colombia
Colombia’s post-market system is built around Tecnovigilancia, established by Resolución 4816 de 2008 with support from Decreto 4725’s Article 61. It is Colombia’s own vigilance terminology and reporting structure. It should not be assumed to mirror EU MDR vigilance mechanics term for term, even where the underlying goals overlap.
The reporting duty is broad. Manufacturers, importers, healthcare providers, independent health professionals and even device users who become aware of an adverse event or incident all have to report it. Reports fall into two tracks, immediate reports for serious adverse events and periodic reports for less urgent findings. INVIMA manages the national Tecnovigilancia network and can order corrective action or market withdrawal based on what comes in.
Manufacturers and importers also carry a few standing obligations that don’t disappear once the registration is issued:
- Traceability records under Article 63
- Notification of market withdrawals under Article 62
- For implantable devices, the tarjeta de implante (implant card), completed for every patient under Article 40
Conclusion
Getting a medical device into the Colombian market comes down to two decisions made right at the start, classification and choice of Colombian importer. The applicable INVIMA procedure, documentation, labeling, and ongoing Tecnovigilancia obligations all trace back to these two calls. So manufacturers planning to enter Colombia should treat classification and importer selection as the priorities worth locking down before anything else gets filed.
If you need support with INVIMA medical device registration, classification, documentation, import requirements or post-market compliance in Colombia, reach out to the experts at info@artixio.com for guidance tailored to your market entry goals.
FAQs
Q1. What authority regulates medical devices in Colombia?
INVIMA is the national authority for sanitary registration, permits and vigilance of medical devices, operating under Decreto 4725 de 2005 and the oversight of the Ministerio de Salud y Protección Social.
Q2. What is the Colombia Medical Device Classification system?
A four-class, risk-based system (Class I, IIa, IIb, III) set out in Decreto 4725 de 2005, based on intended use, invasiveness, duration of contact and whether the device is active or implantable.
Q3. Does a foreign manufacturer need a Colombian importer?
Yes. The Colombian importer files the registration application, holds the CCAA, and is named on the registration itself. There is no separate authorized-representative role independent of the importer under current Colombian rules.
Q4. Is Spanish labeling required?
Yes. Product name, lot number, expiration date where applicable and manufacturer and importer details must appear in Spanish on the label, per Articles 54 and 55 of Decreto 4725.
Q5. Does CE marking allow sales in Colombia?
No. CE marking or FDA clearance can support a filing as evidence of quality or market history in other countries, but neither substitutes for an INVIMA sanitary registration or commercialization permit.
